TrialJournal of Parkinson's disease2026

A randomized safety and feasibility crossover trial of two Mediterranean-ketogenic interventions in individuals with Parkinson's disease.

Kira Tosefsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.